XMAD
NTH
Market cap174mUSD
Jul 09, Last price
2.55EUR
1D
0.00%
1Q
-3.41%
Jan 2017
-46.32%
IPO
-48.90%
Name
Naturhouse Health SA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Naturhouse Health, S.A. is a prominent entity in the global nutrition and weight management sector, maintaining a significant presence across Spain, Italy, France, Poland, and numerous other international markets. The company provides a diverse array of offerings, including food supplements crafted from natural botanical extracts, which are designed to enhance nutrient intake. Additionally, it supplies a variety of specialized dietetic foods and beverages, such as breakfast items, snacks, and meal replacement solutions. Expanding its portfolio, Naturhouse also offers cosmetics and body care products. This line features beauty preparations specifically formulated for skincare during the slimming process, addressing concerns like cellulite and promoting skin firmness, alongside anti-aging treatments. By the end of 2020, its substantial international footprint encompassed 1,788 centers located in 28 countries. These products are distributed to consumers through a network comprising both company-owned and franchised Naturhouse outlets. Established in 1991 and headquartered in Madrid, Spain, the company was previously recognized as Housediet, S.L.U.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||